In this video, Erik Lemay, Head of Global External manufacturing at Servier discusses the manufacture of L-asparaginase, the active pharmaceutical ingredient for Servier’s Acute Lymphoblastic Leukemia (ALL) therapies, and how its collaboration with Lonza has delivered a manufacturing process that gives a 20% improvement in product yield.
You may also be interested in:
Watch this video
Latest content
Latest briefing from the Knowledge Center